TN2012000301A1 - Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée - Google Patents

Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée

Info

Publication number
TN2012000301A1
TN2012000301A1 TNP2012000301A TN2012000301A TN2012000301A1 TN 2012000301 A1 TN2012000301 A1 TN 2012000301A1 TN P2012000301 A TNP2012000301 A TN P2012000301A TN 2012000301 A TN2012000301 A TN 2012000301A TN 2012000301 A1 TN2012000301 A1 TN 2012000301A1
Authority
TN
Tunisia
Prior art keywords
seborrhea
treatment
dihydroxypropyl dodecanoate
dodecanoate
dihydroxypropyl
Prior art date
Application number
TNP2012000301A
Other languages
English (en)
French (fr)
Inventor
Corinne Dechelette
Daniel Redoules
Original Assignee
Pierre Fabre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique filed Critical Pierre Fabre Dermo Cosmetique
Publication of TN2012000301A1 publication Critical patent/TN2012000301A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/08—Mineral waters; Sea water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TNP2012000301A 2009-12-18 2012-06-14 Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée TN2012000301A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0959165A FR2954124B1 (fr) 2009-12-18 2009-12-18 Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee
PCT/EP2010/070028 WO2011073370A2 (fr) 2009-12-18 2010-12-17 Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée

Publications (1)

Publication Number Publication Date
TN2012000301A1 true TN2012000301A1 (fr) 2013-12-12

Family

ID=42358115

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2012000301A TN2012000301A1 (fr) 2009-12-18 2012-06-14 Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée

Country Status (21)

Country Link
US (1) US9101785B2 (enExample)
EP (1) EP2512420B1 (enExample)
JP (1) JP6129557B2 (enExample)
KR (1) KR101774608B1 (enExample)
CN (2) CN106063768A (enExample)
AU (1) AU2010332759B2 (enExample)
BR (1) BR112012014658A2 (enExample)
CA (1) CA2784542C (enExample)
ES (1) ES2757816T3 (enExample)
FR (1) FR2954124B1 (enExample)
GE (1) GEP20146170B (enExample)
IL (1) IL220423A (enExample)
MA (1) MA33842B1 (enExample)
MX (1) MX338441B (enExample)
NZ (1) NZ601279A (enExample)
PT (1) PT2512420T (enExample)
RU (1) RU2568833C2 (enExample)
TN (1) TN2012000301A1 (enExample)
UA (1) UA110332C2 (enExample)
WO (1) WO2011073370A2 (enExample)
ZA (1) ZA201204287B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120016980A (ko) 2010-08-17 2012-02-27 한국전자통신연구원 영상 부호화 방법 및 장치, 그리고 복호화 방법 및 장치
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
FR2992859B1 (fr) 2012-07-09 2014-10-03 Fabre Pierre Dermo Cosmetique Utilisation de coceth sulfate de zinc comme agent antibacterien vis a vis de propionibacterium acnes
US20170165158A1 (en) * 2014-06-24 2017-06-15 Conopco, Inc., D/B/A Unilever Hair treatment composition
WO2018125694A1 (en) * 2017-01-01 2018-07-05 Khalifa University of Science and Technology Compositions from halophyte plants and methods of use thereof
IT201800002843A1 (it) 2018-02-20 2019-08-20 Idi Farm S R L Composizione per l’uso nel trattamento della dermatite seborroica
KR20230132799A (ko) * 2021-01-29 2023-09-18 삐에르화브르데르모-코스메띠끄 여드름 민감성 피부의 일상 관리에 유용한 국소 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3740186A1 (de) * 1987-06-24 1989-01-05 Beiersdorf Ag Desodorierende und antimikrobielle zusammensetzung zur verwendung in kosmetischen oder topischen zubereitungen
US5057501A (en) * 1990-03-13 1991-10-15 Dermatologic Research Corporation Methods for treatment of papulosquamous and eczematous diseases
SE500777C2 (sv) * 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
TW382595B (en) * 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
US5547957A (en) * 1993-10-15 1996-08-20 Merck & Co., Inc. Method of treating androgenic alopecia with 5-α reductase inhibitors
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
FR2731615B1 (fr) * 1995-03-15 1997-07-25 Fabre Pierre Dermo Cosmetique Compositions ecran-solaire comprenant un melange de particules d'oxyde de titane et/ou de zinc, leur procede de preparation et leur utilisation
ZA962455B (en) * 1995-03-31 1996-10-02 B Eugene Guthery Fast acting and persistent topical antiseptic
US6696484B2 (en) * 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
ITMI20011732A1 (it) * 2001-08-07 2003-02-07 Indena Spa Composizioni farmaceutiche e/o cosmetiche orali per il trattamento e la prevenzione di disturbi del cuoio capelluto
ITBS20010111A1 (it) * 2001-12-20 2003-06-20 Paoli Ambrosi Gianfranco De Composizione per uso topico a base dell'estere etilico dell'acido linoleico e e del trietil estere dell'acido citrico associati con opportun
KR100564386B1 (ko) * 2002-05-13 2006-03-27 주식회사 마이코플러스 4-하이드록시-5-메톡시-4-[2-메틸-3-(3-메틸-2-부테닐)-2-옥시란닐]-1-옥사스피로[2,5]옥탄-6-온을 함유한 지루치료용 약제학적 조성물
JP2005040403A (ja) * 2003-07-23 2005-02-17 Shiseido Co Ltd 敏感肌のための美容施術方法
WO2005079164A2 (ja) * 2004-02-10 2005-09-01 Kyushu Tlo Co Ltd ５α−リダクターゼ阻害剤
FR2867973A1 (fr) * 2004-03-26 2005-09-30 B Prince Sarl Lab Composition de soin capillaire contenant du sabal
EP1859774A4 (en) * 2005-02-22 2009-09-30 Maruzen Pharm Co Ltd CAPILLARY COSMETICS
US20090203628A1 (en) * 2008-02-12 2009-08-13 Jan Marini Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition

Also Published As

Publication number Publication date
IL220423A (en) 2016-04-21
CN106063768A (zh) 2016-11-02
AU2010332759A1 (en) 2012-08-09
JP6129557B2 (ja) 2017-05-17
RU2568833C2 (ru) 2015-11-20
CA2784542A1 (fr) 2011-06-23
KR101774608B1 (ko) 2017-09-04
JP2013514328A (ja) 2013-04-25
WO2011073370A2 (fr) 2011-06-23
BR112012014658A2 (pt) 2016-04-05
ES2757816T3 (es) 2020-04-30
MX2012007142A (es) 2012-07-03
PT2512420T (pt) 2019-12-13
MX338441B (es) 2016-04-14
MA33842B1 (fr) 2012-12-03
US20120258065A1 (en) 2012-10-11
EP2512420B1 (fr) 2019-09-04
GEP20146170B (en) 2014-09-25
CN102781415A (zh) 2012-11-14
US9101785B2 (en) 2015-08-11
EP2512420A2 (fr) 2012-10-24
FR2954124A1 (fr) 2011-06-24
UA110332C2 (en) 2015-12-25
RU2012128541A (ru) 2014-01-27
WO2011073370A3 (fr) 2012-07-19
NZ601279A (en) 2015-02-27
ZA201204287B (en) 2013-05-29
AU2010332759B2 (en) 2015-04-16
CA2784542C (fr) 2018-07-17
FR2954124B1 (fr) 2012-04-06
KR20120094501A (ko) 2012-08-24

Similar Documents

Publication Publication Date Title
FR2948016B1 (fr) Orthese pour le traitement de la rhizarthrose
MA33492B1 (fr) Inhibiteurs de bace
MA39211B1 (fr) Composés tricycliques comme agents anti-cancers
MA33842B1 (fr) Utilisation du 2,3-dihydroxypropyl dedecanoate pour le traitement de la seborrhee
MA34593B1 (fr) Analogues de carba-nucleoside subtitues avec le 2'-fluoro pour le traitement antiviral
MA34248B1 (fr) 5-fluoro-1h-pyrazolopyridines substituées et leur utilisation
EP2643018A4 (en) ANTI-IL-6 ANTIBODY FOR THE TREATMENT OF MUNICHCHLEIMHAUTENZÜNDUNGEN
EP2555765A4 (en) TREATMENT OF LOUIS BAR SYNDROME
MA35660B1 (fr) Inhibiteurs de la protéine pak pour le traitement du syndrome de l'x fragile
EP2568999A4 (en) ACTH FOR THE TREATMENT OF AMYOTROPHER LATERAL SCLEROSIS
EP2273989A4 (en) COMBINATION THERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2623494A4 (en) MEDICINE FOR THE TREATMENT OF EYE DISEASES
EP2376091A4 (en) NEW TARGETS FOR THE TREATMENT OF HYPERCHOLESTERINMIA
EP2498603A4 (en) USE OF ANTIBACTERIAL AGENTS FOR THE TREATMENT OF EPITHELINE DISEASES
MA38253B1 (fr) Compositions comprenant de la vortioxétine et du donépézil
EP2427193A4 (en) USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOTION FLUCTUATIONS
EP2654745A4 (en) COMPOSITION FOR THE TREATMENT OF HAIR DRESSES
EP2552200A4 (en) DIMETHYL SUULFOXID (DMSO) FORMULATIONS FOR THE TREATMENT OF AUTISM
EP2582391A4 (en) ARTHRITIS TREATMENT
FR2943249B1 (fr) Utilisation de la decorine pour augmenter la masse musculaire
MA37943B1 (fr) 2-oxo-2,3-dihydro-indoles destinés au traitement de troubles du snc
MA20150279A1 (fr) (r)-nifuratel, son utilisation pour le traitement d'infections et synthèse de (r) et (s)-nifuratel
EP2536436A4 (en) ANTIMIR-451 FOR THE TREATMENT OF POLYCYCLES
EP2398789A4 (en) SPIROPYRROLIDINE DERIVATIVES AS BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
MA34648B1 (fr) Photosensibilisateurs et leur utilisation pour la production d'hydrogène à partir d'eau